MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
1-Year Return
46.22%
This Quarter Return
+7.21%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$17.6B
AUM Growth
-$2.33B
(-12%)
Cap. Flow
-$3.17B
Cap. Flow
% of AUM
-17.97%
Top 10 Holdings %
Top 10 Hldgs %
15.83%
Holding
1,946
New
555
Increased
335
Reduced
444
Closed
606
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$124M |
| 2 |
Merck
MRK
|
+$98.4M |
| 3 |
BERY
Berry Global Group, Inc.
BERY
|
+$96.4M |
| 4 |
Baidu
BIDU
|
+$83.7M |
| 5 |
IQVIA
IQV
|
+$83.1M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$223M |
| 2 |
Las Vegas Sands
LVS
|
+$150M |
| 3 |
Alibaba
BABA
|
+$127M |
| 4 |
Citigroup
C
|
+$127M |
| 5 |
Restaurant Brands International
QSR
|
+$106M |
Sector Composition
| 1 | Healthcare | 24.94% |
| 2 | Technology | 15.43% |
| 3 | Consumer Discretionary | 13.5% |
| 4 | Industrials | 10.49% |
| 5 | Financials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVG
1151
DELISTED
Convergys
CVG
| $347K | ﹤0.01% |
+14,194
| New | +$347K |
|
|
TLP
1152
DELISTED
Transmontaigne
TLP
| $346K | ﹤0.01% |
9,396
-12,676
| -57% | -$467K |
|
1153
Collegium Pharmaceutical
COLL
$1.19B
| $345K | ﹤0.01% |
+14,447
| New | +$345K |
|
1154
Moody's
MCO
$90.8B
| $345K | ﹤0.01% |
2,025
-17,358
| -90% | -$2.96M |
|
1155
Eaton
ETN
$140B
| $344K | ﹤0.01% |
4,600
-14,377
| -76% | -$1.08M |
|
|
MAG
1156
DELISTED
MAG Silver
MAG
| $343K | ﹤0.01% |
+31,649
| New | +$343K |
|
1157
Heartland Express
HTLD
$656M
| $342K | ﹤0.01% |
+18,439
| New | +$342K |
|
|
PGRE
1158
Paramount Group
PGRE
$1.6B
| $331K | ﹤0.01% |
+21,493
| New | +$331K |
|
1159
Catalyst Pharmaceutical
CPRX
$2.42B
| $329K | ﹤0.01% |
+105,345
| New | +$329K |
|
|
OSG
1160
DELISTED
Overseas Shipholding Group Inc.
OSG
| $329K | ﹤0.01% |
+84,719
| New | +$329K |
|
1161
Alexandria Real Estate Equities
ARE
$14.3B
| $328K | ﹤0.01% |
+2,600
| New | +$328K |
|
|
DHC
1162
Diversified Healthcare Trust
DHC
$1.05B
| $328K | ﹤0.01% |
+18,133
| New | +$328K |
|
1163
Aflac
AFL
$57.3B
| $327K | ﹤0.01% |
7,600
-376,883
| -98% | -$16.2M |
|
1164
Prestige Consumer Healthcare
PBH
$3.2B
| $327K | ﹤0.01% |
+8,535
| New | +$327K |
|
1165
Regional Management Corp
RM
$412M
| $326K | ﹤0.01% |
+9,308
| New | +$326K |
|
1166
Bausch Health
BHC
$2.64B
| $323K | ﹤0.01% |
+13,900
| New | +$323K |
|
|
WMC
1167
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $322K | ﹤0.01% |
+3,087
| New | +$322K |
|
1168
Helix Energy Solutions
HLX
$932M
| $320K | ﹤0.01% |
38,417
-70,017
| -65% | -$583K |
|
1169
Credicorp
BAP
$21.2B
| $318K | ﹤0.01% |
1,411
-67,288
| -98% | -$15.2M |
|
1170
Axalta
AXTA
$6.7B
| $317K | ﹤0.01% |
10,445
+3,282
| +46% | +$99.6K |
|
|
STG
1171
Sunlands Technology
STG
$117M
| $316K | ﹤0.01% |
+2,838
| New | +$316K |
|
|
SBBP
1172
DELISTED
Strongbridge Biopharma plc.
SBBP
| $315K | ﹤0.01% |
+52,546
| New | +$315K |
|
1173
Lloyds Banking Group
LYG
$66.8B
| $314K | ﹤0.01% |
94,379
-13,044
| -12% | -$43.4K |
|
1174
Manhattan Associates
MANH
$12.8B
| $312K | ﹤0.01% |
+6,643
| New | +$312K |
|
1175
New York Times
NYT
$9.37B
| $312K | ﹤0.01% |
+12,041
| New | +$312K |
|